You are here: Industry Insights > stem cells

News List

FDA Authorizes Stem Cell Trials for Parkinson’s americanpharmaceuticalreview
June 23, 2021
Hope Biosciences Stem Cell Research Foundation (HBSCRF) has received FDA authorization for a Phase II clinical trial to assess the efficacy and safety of multiple intravenous infusions of allogeneic adipose-derived mesenchymal stem cells in improving ...
European Wellness Advances Clinical Trials on Precursor Stem Cells for Fertility and Immunology into China prnasia
June 22, 2021
European Wellness Biomedical Group (European Wellness) has signed a memorandum of understanding (MOU) with Li Hua Biotechnology to formalize strategic alliance in scientific research and clinical trials development for fertility and immunology in ...
Cancer cells fight for their footing by using an ageing gene worldpharmanews
June 17, 2021
Researchers at the University of Helsinki and the Beatson Institute for Cancer Research in Glasgow have discovered how mutated cells promote their chances to form cancer.
Toxys and Unilever Enter Agreement to Further Validate and Expand ReproTracker® for Animal-Free Developmental Toxicity Assessment b3cnewswire
May 25, 2021
Toxys and Unilever Safety and Environmental Assurance Centre (SEAC) have entered into an agreement to further validate and expand the ReproTracker assay.
NIH scientists identify small-molecule cocktail to prevent cellular stress pharmaceutical-technology
May 06, 2021
The US National Institutes of Health (NIH) scientists have identified a four-part small-molecule cocktail that can provide protection to induced pluripotent stem cells (iPSCs) from stress and preserve regular stem cell structure and function.
Aroa’s Endoform gains validation to recruit stem cells biospectrumasia
August 22, 2020
New Zealand based soft tissue regeneration company Aroa Biosurgery Limited (Aroa) has gained further validation for Endoform®, its flagship extracellular matrix (ECM), with a new study published in the respected international peer-reviewed journal PLOS ON
ProMedica Researchers Observe Encouraging Outcomes with Allogeneic Stem Cells in COVID-19 Patients americanpharmaceuticalreview
August 04, 2020
ProMedica announced promising results of its new study that evaluated the use of stem cells in the treatment of adult COVID-19 patients.
Stem Cells for Everyone: Revolutionizing Regenerative Medicine with Mass Manufacturing of Induced Pluripotent Stem Cells (iPSCs) prnasia
July 16, 2020
I Peace, Inc. (CEO: Koji Tanabe, https://ipeace.com/), a Palo Alto-based biotech startup focusing on Nobel Prize-wining technology of induced pluripotent stem cells (iPSCs) has successfully developed a novel system to mass manufacture clinical-grade iPSCs
Stem cells used to replace neurons in patient with Parkinson’s disease europeanpharmaceuticalreview
May 20, 2020
A team has revealed that a patient who received induced pluripotent stem cells to replace lost dopaminergic neurons has reduced symptoms of Parkinson’s disease.
Induced pluripotent stem cells show success in treating hemophilia A in mice expresspharma
March 13, 2020
In a new study released in STEM CELLS Translational Medicine (SCTM), researchers at the University of California, Davis and the Chinese Academy of Science demonstrate how induced pluripotent ...

Previous page 1 2 3 Next page